These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

763 related items for PubMed ID: 19217698

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Syntheses of new substituted triazino tetrahydroisoquinolines and beta-carbolines as novel antileishmanial agents.
    Kumar A, Katiyar SB, Gupta S, Chauhan PM.
    Eur J Med Chem; 2006 Jan; 41(1):106-13. PubMed ID: 16356594
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani.
    Kaur J, Sundar S, Singh N.
    J Antimicrob Chemother; 2010 Aug; 65(8):1742-8. PubMed ID: 20519355
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and antileishmanial activity of some 1- or 2-(dihydroxyalkyl) and 3-(dihydroxyalkoxy)pyrazolo [3,4-d] pyrimidines.
    Gatta F, Gradoni L, Lupardini E, Gramiccia M, Orsini S.
    Farmaco; 1991 Jan; 46(1):75-84. PubMed ID: 2054043
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
    Marrapu VK, Mittal M, Shivahare R, Gupta S, Bhandari K.
    Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fluorinated rhodacyanine (SJL-01) possessing high efficacy for visceral leishmaniasis (VL).
    Yang M, Arai C, Bakar Md A, Lu J, Ge JF, Pudhom K, Takasu K, Kasai K, Kaiser M, Brun R, Yardley V, Itoh I, Ihara M.
    J Med Chem; 2010 Jan 14; 53(1):368-73. PubMed ID: 19894726
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antiparasitic activity of a triphenyl tin complex against Leishmania donovani.
    Raychaudhury B, Banerjee S, Gupta S, Singh RV, Datta SC.
    Acta Trop; 2005 Jul 14; 95(1):1-8. PubMed ID: 15896700
    [Abstract] [Full Text] [Related]

  • 18. Synthesis of oxysterols and nitrogenous sterols with antileishmanial and trypanocidal activities.
    Bazin MA, Loiseau PM, Bories C, Letourneux Y, Rault S, El Kihel L.
    Eur J Med Chem; 2006 Oct 14; 41(10):1109-16. PubMed ID: 16949702
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy of leishmaniasis. Part IX: synthesis and bioevaluation of aryl substituted ketene dithioacetals as antileishmanial agents.
    Kumar S, Tiwari A, Suryawanshi SN, Mittal M, Vishwakarma P, Gupta S.
    Bioorg Med Chem Lett; 2012 Nov 01; 22(21):6728-30. PubMed ID: 23031588
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and antileishmanial activity of novel buparvaquone oxime derivatives.
    Mäntylä A, Rautio J, Nevalainen T, Vepsälainen J, Juvonen R, Kendrick H, Garnier T, Croft SL, Järvinen T.
    Bioorg Med Chem; 2004 Jul 01; 12(13):3497-502. PubMed ID: 15186834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.